Urticaria Beyond Omalizumab: What is Next?

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGimenez\\-Arnau, Ana M.
dc.contributor.authorSalman, Andac
dc.date.accessioned2025-10-16T15:12:54Z
dc.date.issued2024
dc.identifier.doi10.1007/s40521-024-00372-x
dc.identifier.otherWOS:001280662500001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5665
dc.publisherSPRINGERNATURE
dc.sourceCURRENT TREATMENT OPTIONS IN ALLERGY
dc.subjectBarzolvolimab
dc.subjectBTK inhibitors
dc.subjectChronic urticarial
dc.subjectDupilumab
dc.subjectTreatment
dc.subjectRemibrutinib
dc.subjectUrticaria
dc.titleUrticaria Beyond Omalizumab: What is Next?
dc.typeReview

Dosyalar

Koleksiyonlar

WOS